Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS
L. Adam, R. Kumar, L. E. Arroyo-Garcia, W. H. Molenkamp, J. S. Nowak, H. Klute, A. Farzadfard, R. Alkenayeh, J. Nielsen, H. Biverstal, D. E. Otzen, J. Johansson, A. Abelein
This study shows that the Bri2 BRICHOS domain inhibits α-synuclein oligomer formation and toxicity by suppressing secondary nucleation and binding oligomers, suggesting its potential as a therapeutic target for Parkinson's disease.
bioRxiv · Dec 7, 2023Biophysics